Gadobutrol is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI). It is injected into a vein before the MRI scan. Gadobutrol increases the clarity of the MRI images by making certain areas easier to see. Gadobutrol is used to help diagnose conditions such as -Cancer -Blood vessel abnormalities -Tumors -Infections -Muscle and bone disorders.
Gadobutrol is used for diagnostic purposes in MRIs of the central nervous system (CNS), including the brain and spine. It can also be used to visualize diseases and disorders of the joints. The growing prevalence of neurological disorders and cancer is expected to drive the growth of the gadobutrol market. In addition, the increasing number of MRI procedures being performed is another factor driving the market growth. However, the high cost of gadobutrol and the side effects associated with its use are expected to restrain market growth to a certain extent. Nevertheless, ongoing research and development activities are expected to create opportunities for market expansion in the coming years.
The global gadobutrol market outlook study is a comprehensive databook that provides key market data on the global gadobutrol industry. Some of the prominent players in the market are Advanced Technology & Industrail, BOC Sciences, Bayer HealthCare Pharmaceuticals, Jilin Tely Imp & Exp, JinYan Chemicals (ShangHai), LGM Pharma, Manus Aktteva Biopharma, MedKoo Biosciences, SWAPNROOP DRUGS & PHARMACEUTICALS. The research report on the global gadobutrol market provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and developments, and other information specific to the market.
Covid-19 has had a significant impact on the global gadobutrol market. The outbreak of the pandemic has led to a decrease in demand for gadobutrol, as elective procedures have been postponed or canceled due to the risk of infection. This has resulted in a decline in revenue for manufacturers of gadobutrol. In addition, the restrictions on international travel have hampered the ability of manufacturers to transport gadobutrol to markets outside of the country, where the majority of production takes place.
The covid-19 pandemic has also led to increased competition in the gadobutrol market, as other manufacturers have introduced new products that are similar to gadobutrol. This has put pressure on prices and margins and is expected to continue to do so in the short term. However, long-term prospects for the market remain positive, as there is still significant demand for gadobutrol in various countries
The purpose of this study is to identify the current market environment for gadobutrol and to assess the market's potential for growth over the forecast period. The research delves into market factors affecting the gadobutrol market (drivers, restraints, opportunities, and trends). The current market for gadobutrol is examined in this report, as well as the market's future trajectory.
The second chapter, market overview, provides an overview of the gadobutrol market. The chapter discusses macroeconomic factors, drivers, restraints, opportunities, challenges, value chain analysis, technology roadmap, and Porter 5 force model analysis.
The global gadobutrol market is extensive, with a detailed description and evaluation of the market. It includes extensive qualitative and quantitative insights into the report that are aligned with our intended customers' goals and objectives.
| Attribute | Description |
| Base Year | 2022 |
| Historical Year | 2019 - 2021 |
| Forecast Period | 2023 - 2029 |
| Market Value | US$ Million |
| Segments Covered |
By Product Type: Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL), Pharmacy Bulk Packages (30 mL and 65 mL). By Application: Adults, Children. |
| Geographies Covered |
North America: U.S., Canada Europe: Germany, U.K., France, Italy, Spain, Russia, and the Rest of Europe Asia Pacific: China, India, Japan, Australia, and the Rest of Asia Pacific The Middle East and Africa: GCC, South Africa, and the Rest of Middle East and Africa Latin America: Brazil, Mexico, and the Rest of Latin America |
| Companies | Advanced Technology & Industrail, BOC Sciences, Bayer HealthCare Pharmaceuticals, Jilin Tely Imp & Exp, JinYan Chemicals (ShangHai), LGM Pharma, Manus Aktteva Biopharma, MedKoo Biosciences, SWAPNROOP DRUGS & PHARMACEUTICALS |
Chapter 3, segment analysis provides information on the different sub-segments of the market. The chapter provides an in-depth analysis of the market segments and year-on-year growth projections that enable readers to identify potential market growth areas.
Chapter 4, the regional analysis includes an in-depth analysis of the gadobutrol market by region. The chapter covers several regions, including North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America. The report also includes a comprehensive analysis of the market by country. The report covers countries such as the United States, Canada, Germany, France, Italy, Spain, China, India, Japan, the GCC, South Africa, Brazil, Mexico, and the rest of the world. Regional insight helps market competitors to make crucial decisions about their company. Individualized, country-wise, and segment-wise analyses by region allow readers to explore the potential of the market in different geographies. This section is a vital part of the report for each year’s growth projections and a global share of value.
Chapter 5, a competitive analysis of the report includes company shares analysis, a list of acquisitions, mergers, collaboration, and the introduction of new products.
Chapter 6, the company profile of the report also covers key industry players working in the gadobutrol market. The report also discusses the business strategies adopted by the players at the global, regional, and country-level. The study also focuses on various businesses or inorganic business development strategies for expanding consumer networks through product formation, organization extension, partnerships, mergers, and acquisitions.
1. Introduction
2. Market Overview
2.1. Global Gadobutrol Market Introduction
2.2. Macro- Economic Factor
2.3. Market Determinants
2.3.1. Market Driver
2.3.2. Market Restraints
2.3.3. Market Opportunities
2.3.4. Market Challenges
2.4. Technology/Product Roadmap
2.5. PEST Analysis
2.6. Market Growth Opportunity Analysis
2.7. Impact of Covid-19 on Gadobutrol Market
3. Market Segmentation
3.1. Global Gadobutrol Market Analysis (US$ Mn), By Product Type, 2019 - 2029
3.1.1 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
3.1.2 Pharmacy Bulk Packages (30 mL and 65 mL)
3.2. Global Gadobutrol Market Analysis (US$ Mn), By Application, 2019 - 2029
3.2.1 Adults
3.2.2 Children
4. Regional Analysis
4.1. North America Gadobutrol Market Analysis (US$ Mn), 2019 - 2029
4.1.1. By Country
4.1.1.1. U.S.
4.1.1.2.Canada
4.1.2.By Product Type
4.1.3.By Application
4.2.Europe Gadobutrol Market Analysis (US$ Mn), 2019 - 2029
4.2.1.By Country
4.2.1.1.Germany
4.2.1.2.U.K.
4.2.1.3.France
4.2.1.4.Italy
4.2.1.5.Spain
4.2.1.6.Rest of Europe
4.2.2.By Product Type
4.2.3.By Application
4.3.Asia Pacific Gadobutrol Market Analysis (US$ Mn), 2019 - 2029
4.3.1.By Country
4.3.1.1.China
4.3.1.2.Japan
4.3.1.3.India
4.3.1.4.Rest of Asia Pacific
4.3.2.By Product Type
4.3.3.By Application
4.4.Rest of world Gadobutrol Market Analysis (US$ Mn), 2019 - 2029
4.4.1. By Region
4.4.1.1. Middle East & Africa
4.4.1.2. Latin America
4.4.2.By Product Type
4.4.3. By Application
5.Company Profiles
5.1 Advanced Technology & Industrail
5.2 BOC Sciences
5.3 Bayer HealthCare Pharmaceuticals
5.4 Jilin Tely Imp & Exp
5.5 JinYan Chemicals (ShangHai)
5.6 LGM Pharma
5.7 Manus Aktteva Biopharma
5.8 MedKoo Biosciences
5.9 SWAPNROOP DRUGS & PHARMACEUTICALS